Using rat urinary bladder carcinogenesis induced by N-butyl-4-N-(4-hydroxybutyl) nitrosamine (BBN) as a model, the increased expression of the COX-2 protein was found in preneoplastic and neoplastic lesions of tumor tissues [29], and COX inhibitors exhibited antitumor activity [30]. This evidence concerns the gene PTGS2 and neoplasm.